Don't know a lot about Zelda so I wont bite too much here
BOT is a good comparison for a few reasons, Green Fund has tipped both in their Top 3 AU MedCanns.
BOT doesnt make much rev at all, way less than us because they are a pure bio and have a lot of cash burn but thats all to ensure their trials work out. They are likely going to be taken over if all goes well for them.
Zelda also recently undergoing significant dilution prima facie. That is likely a big reason for their big dump in SP.
I also do not believe they were listed by Dr Sud as one of our peers... I do not know what cannabinoid novel trials they are creating but clearly not anything that Dr Sud and the team see as important. Any evidence to the contrary would be nice but key term here is 'Novel' not just I can make a cannbinoid treatment too. So can MXC and others, not a big deal.
IHL Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
I do not know what cannabinoid novel trials they are creating but clearly not anything that Dr Sud and the team see as important.
